ORTEXORTEX News
Tracking CERS? Get live short interest, options flow, and signals on ORTEX.Sign up free →
CE
Earnings PreviewCERS

CERS Bears Quietly Accumulate Into August Print

By ORTEX News · Edited by , Editor, ORTEX News2 min readdata as of 31 Jul 2026, 04:00

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Cerus Corporation heads into its August 3 earnings report with short sellers meaningfully more active than a month ago — yet the borrow market shows no urgency on either side.

The short interest story is the most notable setup heading into the print. Bears have added roughly 22% more short exposure over the past month, lifting short interest to nearly 7% of the free float — a level worth watching for a stock trading at $2.89. The bulk of that build happened in late June and early July, when short interest briefly ran above 19 million shares before pulling back to around 13.3 million. The one-week change of 6.2% confirms the direction of travel is still higher. That said, the borrow market itself is relaxed: availability is running at over 1,700% of current short interest — far more supply than demand — and cost to borrow sits at just 0.44%, down roughly 9% over the past week. There is no squeeze pressure here; shorts are adding positions into ample liquidity.

Options positioning offers a mild contrarian signal. Call-heavy positioning dominates — the put/call ratio of 0.14 is above its 20-day average of 0.12, but only fractionally so, with a z-score below 1. By the standards of the past year, this remains deeply call-skewed: the 52-week high on the PCR was 0.44, suggesting option buyers are generally leaning bullish despite the growing short interest. Those two signals sit in direct tension.

The analyst debate leans constructively on paper, though recent coverage is thin. The most current move of note came from BTIG, which upgraded CERS to Buy in early May with a $4.00 target — roughly 38% above the current price. The consensus across three active buy-rated analysts points to meaningful upside from current levels. The caveat is that most of the underlying notes are stale: Stifel cut its target to $3.00 from $6.00 back in October 2024, a reminder that the bull case has been repeatedly walked down. The stock is loss-making — the trailing PE is deeply negative — and the EV/EBITDA multiple near 23.8x is not cheap for a company that has struggled to demonstrate consistent profitability. Bears have a straightforward valuation argument to anchor their trade.

The earnings history adds one concrete data point: the most recent prior release triggered a 6.3% one-day decline and extended to a 9.2% loss over the following five days. Institutional positioning provides limited additional clarity — ARK and BlackRock are both on the register with meaningful stakes, but neither showed dramatic moves in the most recent reporting period. The August 3 print will test whether the short-side conviction that has quietly built over the past four weeks is vindicated by the fundamentals, or whether the call-dominant options market is reading the setup more accurately.

Stocks in this article

See the live data behind this article on ORTEX.

Open CERS on ORTEX →

How this article was generated

Generated
31 Jul 2026, 04:14
Data as of
31 Jul 2026, 04:00
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notes

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.